Improving health and social care through evidence-based guidance

Find NICE guidance

Browse guidance by area:

Conditions and diseases

Health and social care delivery

Health protection

Lifestyle and wellbeing

Population groups

Settings

  • About us
  • Put guidance into practice
  • Find journals and databases
  • Financial planning
  • Get involved

Latest guidance  

Abortion care
Accuro for guiding epidural or spinal anaesthesia
AcQMap for mapping the heart atria to target ablation treatment for arrhythmias
Venous thromboembolism in adults: diagnosis and management
COVID-19 rapid evidence summary: Sarilumab for COVID-19

Latest guidance in consultation  

Abiraterone for treating newly diagnosed high risk metastatic hormone-naive prostate cancer [ID945]
Chronic kidney disease: assessment and management (update)
Ozanimod for treating relapsing-remitting multiple sclerosis [ID1294]
Chlormethine gel for treating mycosis fungoides-type cutaneous T-cell lymphoma [ID1589]
Clostridioides difficile infection: antimicrobial prescribing

Explore NICE

  1. News|
  2. About|
  3. Events|
  4. Get involved

We're looking for a new deputy director of finance - strategy and commercial

Find resources to help you put guidance into practice

NICE and LSE's MSc Evaluation of Health Care Interventions and Outcomes

Support for industry to engage with us during health technology development

Our role in patient safety

We’re co-hosting the Health Technology Assessment International Annual Meeting in June - find out more

Latest news  

  1. NHS patients to benefit from first full access deal in Europe for new CAR-T therapy recommended by NICE
  2. Treatment for men with enlarged prostate is recommended by NICE for NHS adoption
  3. NICE collaboration on streamlined licensing and patient access process for new medicines opened on January 1st
  4. Shared decision making is an integral part of healthcare, says NICE

Tweets

by @NICEcomms
Tweets by NICEcomms
Tweets by NICEcomms